CSF biomarker variability in the Alzheimer's Association quality control programNiklas Mattsson, Olivier Bousiges, Ulf Andréasson et al.|Alzheimer s & Dementia|2013Cited by 386
Sample Handling for Mass Spectrometric Proteomic Investigations of Human SeraM. West-Nielsen, Niels H. H. Heegaard, Estrid Høgdall et al.|Analytical Chemistry|2005Cited by 150
Cu(II) Mediates Kinetically Distinct, Non-amyloidogenic Aggregation of Amyloid-β PeptidesJeppe T. Pedersen, Niels H. H. Heegaard|Journal of Biological Chemistry|2011Cited by 120
Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in DenmarkViktoria Papp, Thor Petersen, Poul Erik Jensen et al.|Neurology|2018Cited by 104
Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromesSára Bech, Kristian Winge, Lena E. Hjermind et al.|Parkinsonism & Related Disorders|2011Cited by 48